Page last updated: 2024-12-08

n-bromoacetylethanolamine phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-bromoacetylethanolamine phosphate: inhibits 6-phosphofructo-2-kinase; affinity labeling reagent for aldolase & other enzymes; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID188343
CHEMBL ID4751366
SCHEMBL ID4314679
MeSH IDM0073621

Synonyms (9)

Synonym
52011-43-5
n-bromoacetylethanolamine phosphate
SCHEMBL4314679
2-[(2-bromoacetyl)amino]ethyl dihydrogen phosphate
acetamide, 2-bromo-n-(2-(phosphonooxy)ethyl)-
DTXSID60199984
bromoacetamide-peg1-phosphate
CHEMBL4751366
PD167775
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1693203Inhibition of Trypanosoma cruzi RPE1 assessed as residual activity at 1 mM relative to control
AID1693204Inhibition of Trypanosoma cruzi RPE1 assessed as residual activity at 2 mM relative to control
AID1693201Inhibition of Trypanosoma cruzi RPE1 assessed as residual activity at 0.2 mM relative to control
AID1693200Inhibition of Trypanosoma cruzi Ribose 5-phosphate isomerase type B assessed as residual activity at 2 mM using ribose 5-phosphate as substrate relative to control
AID1693210Cytotoxicity against mouse NIH/3T3 cells
AID1693202Inhibition of Trypanosoma cruzi RPE1 assessed as residual activity at 0.5 mM relative to control
AID1693209Trypanocidal activity against Trypanosoma cruzi trypomastigotes expressing beta galactosidase infected in NIH/3T3 cells assessed as parasite growth inhibition at >= 50 uM by reporter assay
AID1693197Inhibition of Trypanosoma cruzi Ribose 5-phosphate isomerase type B assessed as residual activity at 0.2 mM using ribose 5-phosphate as substrate relative to control
AID1693199Inhibition of Trypanosoma cruzi Ribose 5-phosphate isomerase type B assessed as residual activity at 1 mM using ribose 5-phosphate as substrate relative to control
AID1693198Inhibition of Trypanosoma cruzi Ribose 5-phosphate isomerase type B assessed as residual activity at 0.5 mM using ribose 5-phosphate as substrate relative to control
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (41.18)18.7374
1990's6 (35.29)18.2507
2000's3 (17.65)29.6817
2010's0 (0.00)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.31 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]